IHC staining of PXS-S1C-treated mice demonstrated reduced Ki-67 staining (proliferation marker) compared to no inhibitor-treated control mice (Fig. 2e) and lower expression of LOXL2 in tongue tumor samples in treated mice (Fig. 2f). This evidence concerns the gene LOXL2 and tongue neoplasm.